Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR3 | P51677 | 4/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | CALCRL | Q16602 | 9/20 | 0.47 |
| ▸ | PLD2 | O14939 | 1/20 | 0.47 |
| ▸ | PLD1 | Q13393 | 1/20 | 0.47 |
| ▸ | TNKS | O95271 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.44 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.44 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22587878 | 0.90 | PLD2 (0.47) | CCR3CALCRLPLD2PLD1TNKS | |
| SCHEMBL31285905 | 0.90 | PLD2 (0.47) | CCR3CALCRLPLD2PLD1TNKS | |
| SCHEMBL22605644 | 0.88 | PLD2 (0.45) | CCR3CALCRLPLD2PLD1TNKS | |
| SCHEMBL22587782 | 0.88 | PLD2 (0.45) | CCR3CALCRLPLD2PLD1TNKS | |
| SCHEMBL31285913 | 0.88 | PLD2 (0.45) | CCR3CALCRLPLD2PLD1TNKS | |
| SCHEMBL29518321 | 0.88 | PLD2 (0.45) | CCR3CALCRLPLD2PLD1TNKS | |
| SCHEMBL24368197 | 0.86 | CALCRL (0.53) | CCR3OPRM1CALCRLPLD2PLD1 | |
| SCHEMBL29518303 | 0.86 | CALCRL (0.53) | CCR3OPRM1CALCRLPLD2PLD1 | |
| SCHEMBL22605698 | 0.86 | PLD2 (0.62) | CALCRLPLD2PLD1TNKSPARP1 | |
| SCHEMBL29518452 | 0.86 | PLD2 (0.62) | CALCRLPLD2PLD1TNKSPARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020216378-A1 | HETEROCYCLIC COMPOUND, APPLICATION THEREOF, AND COMPOSITION CONTAINING SAME | 健艾仕生物医药有限公司 | 2020-10-29 | — | — | WO | disclosed |